HKI 357

HKI 357 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:HKI-357
CAS:848133-17-5
Purity:98.00% Package:1 mg;10 mg;100 mg;200 mg;25 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:HKI 357
CAS:848133-17-5
Purity:>=98%(HPLC) Package:$187.9/5mg;$286.9/10mg;$583.9/25mg;$929.9/50mg;$1484.9/100mg;Bulk package Remarks:98%(HPLC)
Company Name: Amadis Chemical Company Limited
Tel: 571-89925085
Email: sales@amadischem.com
Products Intro: Product Name:HKI 357
CAS:848133-17-5
Purity:0.97 Package:mgs,gs,kgs Remarks:A900842
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Products Intro: Product Name:HKI-357
CAS:848133-17-5
Purity:98% HPLC Package:5mg,10mg,50mg,100mg,1g,5g
Company Name: EMMX Biotechnology LLC  
Tel: 888-539-0666
Email: info@emmx.com
Products Intro: Product Name:HKI 357
CAS:848133-17-5
Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
HKI 357 Basic information
Product Name:HKI 357
Synonyms:HKI 357;2-Butenamide, N-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-, (2E)-;(2E)-N-[[4-[[(3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide;Inhibitor,HKI-357,ErbB-1,HER1,inhibit,NSCLCs,Epidermal growth factor receptor,HKI 357,EGFR,ERBB2,HKI357
CAS:848133-17-5
MF:C31H29ClFN5O3
MW:574.05
EINECS:
Product Categories:
Mol File:848133-17-5.mol
HKI 357 Structure
HKI 357 Chemical Properties
Boiling point 747.6±60.0 °C(Predicted)
density 1.34±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Soluble to 100 mM in DMSO and to 25 mM in ethanol
form Powder
pka12.37±0.43(Predicted)
color Off-white to yellow
Safety Information
MSDS Information
HKI 357 Usage And Synthesis
Biological ActivityHKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 with IC50 of 34 nM and 33 nM, respectively. It can inhibit EGFR autophosphorylation (detected at Y1068), and AKT and MAPK phosphorylation.
in vitro

HKI-357 (0.01-10 μM) is effective in suppressing ligand-induced EGFR autophosphorylation and its downstream signaling, as determined by AKT and MAPK phosphorylation in NCI-H1975 cells. HKI-357 is also effective in suppressing EGFR autophosphorylation (measured at residue Y1068), and AKT and MAPK phosphorylation in parental NCI-H1650 cells harboring the delE746-A750 EGFR mutation.

Western Blot Analysis

< tr>
Cell Line: NCI-H1975 bronchoalveolar cell line
Concentration: 0.01, 0.01, 0.1, 1 and 10 μM
Incubation Time:
Result: Suppressed ligand-induced EGFR autophosphorylation and its downstream signaling AKT and MAPK phosphorylation.
target

EGFR

34 nM (IC 50 )

ErbB2

33 nM (IC 50 )

HKI 357 Preparation Products And Raw materials
Tag:HKI 357(848133-17-5) Related Product Information